Deep Track Capital, L.P. 13F annual report
By Robert King
Deep Track Capital, L.P. is an investment fund managing more than $2.29 trillion ran by Nir Messafi. There are currently 57 companies in Mr. Messafi’s portfolio. The largest investments include Immunovant Inc and IVERIC bio Inc, together worth $341 billion.
Limited to 30 biggest holdings
$2.29 trillion Assets Under Management (AUM)
As of 7th February 2023, Deep Track Capital, L.P.’s top holding is 9,710,000 shares of Immunovant Inc currently worth over $172 billion and making up 7.5% of the portfolio value.Relative to the number of outstanding shares of Immunovant Inc, Deep Track Capital, L.P. owns less than approximately 0.1% of the company.In addition, the fund holds 7,878,119 shares of IVERIC bio Inc worth $169 billion, whose value fell approximately 0.1% in the past six months. The third-largest holding is Jazz Pharmaceuticals plc worth $139 billion and the next is Travere Therapeutics Inc worth $96.4 billion, with 4,582,000 shares owned.
Currently, Deep Track Capital, L.P.'s portfolio is worth at least $2.29 trillion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Deep Track Capital, L.P.
The Deep Track Capital, L.P. office and employees reside in Greenwich, Connecticut. According to the last 13-F report filed with the SEC, Nir Messafi serves as the CCO/COO/CFO at Deep Track Capital, L.P..
